A Phase 1/2 Study on the Safety of Rovalpituzumab Tesirine Administered in Combination with Nivolumab or Nivolumab and Ipilimumab for Adults with Extensive-Stage Small Cell Lung Cancer
Clinical Trial Grant
Awarded By
AbbVie Inc.
Start Date
September 5, 2017
End Date
September 1, 2020
Awarded By
AbbVie Inc.
Start Date
September 5, 2017
End Date
September 1, 2020